65
Foresee Pharmaceuticals Co., Ltd.
6576.TWO · TWO
$80.00 -1.36% (-$1.10)
1M +2.01%
Market Cap $12.8B
P/E Ratio 567.25x
Div. Yield -
ROE 2.06%
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/E 567.25x
P/B 9.15x
P/S 27.09x
Growth
67 /100
Growing Rev. growth 12.67%
Book val. growth 0.69%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 22.10%
FCF margin 167.39%
Net margin 4.77%
Quality
7 /100
Poor ROIC 6.65%
Asset turnover 0.24x
ROE 2.06%
Debt
69 /100
Low Debt/Equity 0.29x
Int. coverage -86.80x
Current ratio 13.61x
Stability
28 /100
Unstable Beta 0.58x
Profitable years 0
Rev. volatility 77.92%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na 6576.TWO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Benjamin Chien
Employees
1,760
Headquarters
Taipei
Nadcházející události
06 LIS
Earnings
Upcoming earnings report